Clinical Trial

Metabolomics During ElectroConvulsivoTherapy

Study acronym: METECT
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated July 24, 2025 (before its estimated October 15, 2025 completion). Its status may not reflect the trial's current state.
Summary
Investigators will measure the variation of blood Metabolome through 1H NMR at several time points during the course of electroconvulsivetherapy in patients with a major depressive episode. Patients with a major depressive disorder or a bipolar disorder and a current major depressive episode will be included in this study. Investigators hypothesized that Metabolome could be a source to predict response during ECT and to help understanding underlying biological mechanisms.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2023-07-25; most recent amendment 2025-07-23.
Status change: Not Yet Recruiting → Recruiting 2024-07-05
Trial Details
NCT Number NCT05973643
Lead Sponsor Hôpital le Vinatier
Conditions Major Depressive Episode, ECT
Enrollment 50 participants
Start Date 2024-03-11
Primary Completion 2025-10-15 (estimated)
Study Completion 2026-10-15 (estimated)
Updated on ClinicalTrials.gov 2025-07-24